PO.TB09.02 · 肿瘤生物学

整合基因组和转录组分析揭示星形细胞瘤的空间和演化动态

Integrated genomic and transcriptomic profiling uncovers spatial and evolutionary dynamics in astrocytoma

海报缩略图:整合基因组和转录组分析揭示星形细胞瘤的空间和演化动态
编号 3545 展板 21 时间 4/20 02:00–05:00 区域 Section 33 主讲 Serafiina Jaatinen, BS;MS
分会场 Tumor Evolution
查看 PDF 下载 PDF 🔒 查看 / 下载完整 PDF 需登录并开通下载套餐 · 查看套餐 / 开通 AACR 官方页面

作者与单位 Authors & Affiliations

Serafiina Jaatinen1, Sonja Mäntylä1, Reetta Nätkin1, Ismail Hermelo1, Anssi Nurminen1, Aliisa Tiihonen1, Iida Salonen1, Elisa M. Vuorinen1, Kristiina Nordfors2, Hannu Haapasalo3, Kirsi Rautajoki1, Joonas Haapasalo4, Matti Nykter1

1Tampere University, Faculty of Medicine and Health Technology, Tampere, Finland,2Tampere University Hospital, Unit of Pediatric Haematology and Oncology, Tampere, Finland,3Fimlab Laboratories ltd. and Tampere University, Tampere, Finland,4Tampere University Hospital and Tampere University, Department of Neurosurgery, Tampere, Finland

摘要 Abstract

中文摘要
胶质母细胞瘤的瘤内基因组异质性通过克隆演化产生,可能促成治疗耐药和不良结局,然而亚克隆多样性与转录状态之间的相互作用仍未被充分理解。我们利用多样本全基因组测序(WGS)、批量RNA测序和单细胞RNA测序(scRNA-seq),全面绘制瘤内转录组和基因组异质性的层次,并在两例胶质母细胞瘤和一例IDH突变型高级别星形细胞瘤患者的十二个空间上不同的肿瘤区域中追踪演化谱系。在IDH突变型星形细胞瘤中,肿瘤演化的特征是早期全基因组倍增,随后是2号染色体与X染色体之间罕见的染色体碎裂,以及富含短插入和缺失的区域特异性超突变。相比之下,两例胶质母细胞瘤均表现出由早期克隆性拷贝数改变和单核苷酸变异所促进的线性演化,其中一例患者出现广泛的杂合性缺失、染色体外DNA结构和高倍性。单细胞拷贝数分析验证了该患者中WGS定义的克隆,并揭示了在批量测序中无法检测到的、具有独特拷贝数改变的额外亚克隆,从而完善了该肿瘤的系统发育树。转录组分析揭示了胶质母细胞瘤细胞状态中区域和克隆特异性的差异,而IDH突变型肿瘤区域除了星形细胞瘤样程序外,通常还表现出神经祖细胞样活性。胶质母细胞瘤样本以星形细胞瘤样状态为主,但频繁显示间充质样和内皮样转录活性,并伴有更罕见、更异质的神经祖细胞样或少突胶质前体样细胞小生境,以及增高的增殖和独特的成熟特征。此外,scRNA-seq衍生的亚克隆在间充质样表达上显示差异,并呈现与批量RNA-seq中观察到的状态差异相似的转录分支,反映了基于WGS的克隆。总之,这些结果表明成人弥漫性星形细胞瘤的瘤内异质性源于基因组分化和显著的转录可塑性,而这些侵袭性肿瘤之间的患者间多样性仍然很高。通过将单细胞和批量转录谱与演化谱系相连接,我们的多组学框架为弥漫性星形细胞瘤演化和恶性细胞状态组织提供了详细的见解。
查看英文原文 English abstract
Intratumoral genomic heterogeneity in glioblastoma arises through clonal evolution and may contribute to treatment resistance and poor outcomes, yet the interplay between subclonal diversity and transcriptional states remains incompletely understood. We utilized multi-sampled whole-genome sequencing (WGS), bulk RNA sequencing, and single-cell RNA sequencing (scRNA-seq) to comprehensively map the layers of intratumoral transcriptomic and genomic heterogeneity and trace the evolutionary lineages across twelve spatially distinct tumor regions in two glioblastoma and one IDH mutant high-grade astrocytoma patients. In the IDH mutant astrocytoma, tumor evolution was characterized by early whole-genome duplication followed by a rare chromothripsis between chromosomes 2 and X, as well as region-specific hypermutation enriched for short insertions and deletions. In contrast, both glioblastomas exhibited linear evolution facilitated by early clonal copy number alterations and single-nucleotide variants, and in one patient, extensive loss of heterozygosity, extrachromosomal DNA structures, and high ploidy. Single-cell copy number analysis validated WGS-defined clones in this patient and uncovered additional subclones with distinct copy number alterations undetectable in bulk sequencing, refining the tumor's phylogenetic tree. Transcriptomic profiling revealed region- and clone-specific differences in glioblastoma cell states, while IDH mutant tumor regions generally exhibited neural progenitor-like activity in addition to astrocytoma-like programs. Glioblastoma samples were dominated by astrocytoma-like states but frequently displayed mesenchymal and endothelial-like transcriptional activity, with rarer and more heterogeneous niches of neural progenitor-like or oligodendrocyte precursor-like cells along with elevated proliferation and distinct maturation signatures. Moreover, scRNA-seq-derived subclones showed differences in mesenchymal-like expression and similar transcriptional branching with state differences observed in bulk RNA-seq, reflecting WGS-based clones. Together, these results demonstrate that intratumoral heterogeneity in adult diffuse astrocytomas arises from both genomic divergence and substantial transcriptional plasticity, while inter-patient diversity remains high across these aggressive tumors. By linking single-cell and bulk transcriptional profiles to evolutionary lineages, our multi-omic framework provides detailed insight into diffuse astrocytoma evolution and malignant cell-state organization.
利益披露 Disclosure
S. Jaatinen, None.. S. Mäntylä, None.. R. Nätkin, None.. I. Hermelo, None.. A. Nurminen, None.. A. Tiihonen, None.. I. Salonen, None. E. M. Vuorinen, Eli Lilly and Company Employment. K. Nordfors, None. H. Haapasalo, Fimlab Laboratories ltd. Employment. K. Rautajoki, None.. J. Haapasalo, None. M. Nykter, Genevia Technologies g., Board of Directors, non-salaried role), Other Business Ownership.

← 返回 AACR 2026 检索